Articles Published in 2011

Middle East region poised for clinical trials growth

Monday, October 24, 2011 08:00 AM

With sponsors and CROs still on the hunt for emerging markets rife with treatment-naive patients and good infrastructure, interest in the Middle East is increasing.

More... »

GenoLogics secures $8 million in strategic financing

Friday, October 21, 2011 02:14 PM

GenoLogics has raised $8 million in strategic financing led by new investor Illumina. The financing will be used to accelerate product development for future clinical applications and new desktop sequencing systems, and to expand sales and marketing functions.

More... »

The University Hospital selects RayStation for advanced research

Friday, October 21, 2011 02:06 PM

RaySearch Laboratories has received an order for its RayStation treatment planning system from The University Hospital of Columbia and Cornell in New York.

More... »

ICON receives contract award from FNIH

Friday, October 21, 2011 01:38 PM

ICON has received a contract award from the Foundation for the National Institutes of Health (FNIH) to provide clinical support for the Biomarkers Consortium study entitled Characterization of the Variability of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Healthy Subjects. 

More... »

IRX Therapeutics relocates creating 280 jobs in Florida

Friday, October 21, 2011 12:08 PM

St. Petersburg, Fla. - Gov. Rick Scott has reported the relocation of IRX Therapeutics, a clinical stage biotechnology company, to St. Petersburg from New York City by the year's end.  The company will staff more than 280 positions within five years at a projected minimum average wage of $90,000 annually.

More... »

Eagle Awards honor GSK, Medpace, Quorum IRB

Friday, October 21, 2011 11:14 AM

Sponsor GlaxoSmithKline, CRO Medpace and IRB Quorum Review all took home the coveted Eagle Award last Saturday, honored by investigative sites at the sixth annual Site Solutions Summit.

More... »

Parkinson’s Disease Foundation adds 27 research adovcates

Thursday, October 20, 2011 02:43 PM

The Parkinson's Disease Foundation welcomes 27 new members to its national network of research advocates who are influencing research and speeding the development of new and effective treatments for Parkinson's.  This week in New Jersey, the members from the Northeast region are completing an intensive three-day training to prepare them to join the network, known as Parkinson's Advocates in research.

More... »

Taigle becomes SAFE-BioPharma partner

Thursday, October 20, 2011 01:21 PM

Taigle has become a vendor partner of SAFE-BioPharma, the non-profit that manages the SAFE-BioPharma digital identity and signature standard for the biopharmaceutical and healthcare industries. The SAFE-BioPharma standard allows its member companies to meet security and confidentiality needs specific to the life sciences.

More... »

goBalto secures Series A financing

Thursday, October 20, 2011 11:51 AM

goBalto, developer of new generation web-based clinical research solutions, has raised an undisclosed amount in Series A financing from Silicon Valley-based health technology investors Aberdare Ventures and the West Health Investment Fund. The funds will be used to expand goBalto's corporate activities and to enhance Tracker, its Software-as-a-Service (SaaS) clinical trials platform that was launched in June 2011.

More... »

Oncothyreon advances to phase II of PX-866 trial

Thursday, October 20, 2011 11:19 AM

Oncothyreon it has initiated the phase II portion of  its ongoing phase I/II trial of PX-866 in combination with the chemotherapeutic agent  docetaxel (Taxotere) following successful completion of the phase I dose escalation portion  of the study. PX-866 is a small molecule compound designed to inhibit  the activity of phosphatidylinositol-3-kinase (PI-3K), a component of  an important cell survival signaling pathway.

More... »